Status:
TERMINATED
Parecoxib In Post Surgery (Hemicolectomy) Pain
Lead Sponsor:
Pfizer
Conditions:
Colectomy
Eligibility:
All Genders
18-80 years
Phase:
PHASE3
Brief Summary
This is a phase III, multicenter, open label, pilot to evaluate the analgesic efficacy and safety of parecoxib 40 mg IV in the treatment of the pain following hemicolectomy in an optimal management of...
Detailed Description
The study was terminated prematurely due to recruitment issues on 31 January 2006. Safety concerns did not lead to the decision to terminate this study.
Eligibility Criteria
Inclusion
- patients hospitalised for resection of left/right colon;
- preoperative health graded as ASA \<3.
Exclusion
- patients with any type of metastatic cancer, particularly metastatic colon cancer;
- patients with familial adenomatous polyps (sporadic adenomatous polyps are accepted);
Key Trial Info
Start Date :
September 1 2002
Trial Type :
INTERVENTIONAL
End Date :
January 1 2005
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00139607
Start Date
September 1 2002
End Date
January 1 2005
Last Update
August 14 2009
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Biella, Italy, 13051
2
Pfizer Investigational Site
Milan, Italy, 20123
3
Pfizer Investigational Site
Siena, Italy, 53100